Nutriband Inc (NTRB)

NASDAQ
3.97
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    3.81 - 3.97
  • 52 wk Range:
    2.41 - 10.44

NTRB Overview

Prev. Close
3.97
Day's Range
3.81-3.97
Revenue
1.43M
Open
3.95
52 wk Range
2.41-10.44
EPS
-0.843
Volume
0
Market Cap
30.98M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
13,121
P/E Ratio
-4.89
Beta
-0.226
1-Year Change
-29.48%
Shares Outstanding
7,803,263
Next Earnings Date
Dec 28, 2022
What is your sentiment on Nutriband?
or
Vote to see community's results!

Nutriband Inc News

Nutriband Inc Company Profile

Nutriband Inc Company Profile

Employees
13

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Read More

Analyst Price Target

Average13.29 (+234.65% Upside)
High18
Low8.5714
Price3.97
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • 🚀
    0